|
MBD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.795900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5812399999926E-05 |
| Normal-vs-Stage2 |
5.514800E-01 |
| Normal-vs-Stage3 |
8.595200E-01 |
| Normal-vs-Stage4 |
3.579200E-01 |
| Stage1-vs-Stage2 |
4.177800E-02 |
| Stage1-vs-Stage3 |
6.984600E-04 |
| Stage1-vs-Stage4 |
1.85731999999827E-05 |
| Stage2-vs-Stage3 |
6.556000E-01 |
| Stage2-vs-Stage4 |
2.280000E-01 |
| Stage3-vs-Stage4 |
3.434600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.226300E-02 |
| Normal-vs-AfricanAmerican |
1.519270E-03 |
| Normal-vs-Asian |
1.428240E-01 |
| Caucasian-vs-AfricanAmerican |
1.181560E-02 |
| Caucasian-vs-Asian |
1.964380E-01 |
| AfricanAmerican-vs-Asian |
9.719800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.113800E-01 |
| Normal-vs-Female |
1.85565999999415E-05 |
| Male-vs-Female |
2.994200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.422800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.862300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.049400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.875400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.096000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.591400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.690600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.453800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.062000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.925400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.015710E-03 |
| Normal-vs-Grade 2 |
1.83574999998992E-05 |
| Normal-vs-Grade 3 |
5.962800E-01 |
| Normal-vs-Grade 4 |
7.227500E-02 |
| Grade 1-vs-Grade 2 |
1.404210E-03 |
| Grade 1-vs-Grade 3 |
1.44809999991224E-07 |
| Grade 1-vs-Grade 4 |
2.44560000028926E-08 |
| Grade 2-vs-Grade 3 |
1.049910E-04 |
| Grade 2-vs-Grade 4 |
3.67169999959671E-07 |
| Grade 3-vs-Grade 4 |
3.037600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.2143000000252E-07 |
| Normal-vs-ccB subtype |
6.180600E-01 |
| ccA subtype-vs-ccB subtype |
4.82180000038746E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.541700E-02 |
| Normal-vs-N1 |
7.569600E-01 |
| N0-vs-N1 |
4.110200E-01 |
|
|
